Atlas Trials

Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency

Clinical trial NCT03767270 · WITHDRAWN

Trial details

NCT number
NCT03767270
Sponsor
Translate Bio, Inc.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ornithine Transcarbamylase Deficiency
Start date
2019-12-01
Primary completion
2022-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.